Cg Oncology Inc (NASDAQ: CGON) kicked off on Monday, up 3.79% from the previous trading day, before settling in for the closing price of $25.62. Over the past 52 weeks, CGON has traded in a range of $14.80-$40.47.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -32.61%. With a float of $44.63 million, this company’s outstanding shares have now reached $76.22 million.
In an organization with 113 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 98.94%, operating margin of -20302.27%, and the pretax margin is -15945.17%.
Cg Oncology Inc (CGON) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cg Oncology Inc is 41.45%, while institutional ownership is 68.21%. The most recent insider transaction that took place on May 21 ’25, was worth 28,000. In this transaction Director of this company sold 1,000 shares at a rate of $28.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Apr 28 ’25, when Company’s Director sold 1,000 for $30.76, making the entire transaction worth $30,760. This insider now owns 0 shares in total.
Cg Oncology Inc (CGON) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -32.61% per share during the next fiscal year.
Cg Oncology Inc (NASDAQ: CGON) Trading Performance Indicators
Take a look at Cg Oncology Inc’s (CGON) current performance indicators. Last quarter, stock had a quick ratio of 30.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3070.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.39, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.70 in one year’s time.
Technical Analysis of Cg Oncology Inc (CGON)
Let’s dig in a bit further. During the last 5-days, its volume was 0.79 million. That was inferior than the volume of 1.06 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 48.55%. Additionally, its Average True Range was 1.75.
During the past 100 days, Cg Oncology Inc’s (CGON) raw stochastic average was set at 67.37%, which indicates a significant decrease from 68.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.49% in the past 14 days, which was lower than the 84.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.65, while its 200-day Moving Average is $30.40. However, in the short run, Cg Oncology Inc’s stock first resistance to watch stands at $27.20. Second resistance stands at $27.82. The third major resistance level sits at $28.68. If the price goes on to break the first support level at $25.72, it is likely to go to the next support level at $24.86. The third support level lies at $24.24 if the price breaches the second support level.
Cg Oncology Inc (NASDAQ: CGON) Key Stats
The company with the Market Capitalisation of 2.03 billion has total of 76,225K Shares Outstanding. Its annual sales at the moment are 1,140 K in contrast with the sum of -88,040 K annual income. Company’s last quarter sales were recorded 50 K and last quarter income was -34,450 K.
